GL1X · GenesisL1 explorer

MolNFT v1 · #74534 · protein

Crystal structure of human transthyretin variant A25T in complex with thyroxine (T4)

3OZK: “Crystal structure of human transthyretin variant A25T in complex with thyroxine (T4)”. X-ray diffraction, 1 ligand (T44), 3 pockets (best druggability 0.36). MolNFT v1 #74534 on GenesisL1: 3D structure, binding sites and pockets in…

PDB
3OZK
Type
protein
Length
231 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Transthyretin
UniProt
P02766
Ligands
T44
Pockets
3 · best druggability 0.36

Structure

x-ray diffraction · 2 distinct chains · 6% helix, 51% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ATransthyretinprotein1166% helix, 51% strandP02766
BTransthyretinprotein1157% helix, 51% strandP02766

Ligands and binding sites

  • T44 · 3,5,3',5'-tetraiodo-L-thyronine · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1670.360.7816empty
2850.330.7419empty
3630.330.7614empty

Interfaces

1 interface between chains.

  • A–B · 913 Ų buried · 20 hydrogen bonds · protein-protein

Compared structures

  • 3OZK · Crystal structure of human transthyretin variant A25T in complex with thyroxine (T4) · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.